SCHEMBL1258404

SCHEMBL1258404

CCONCCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
SIGMAR1 Q99720 6/20 0.48
RAB9A P51151 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 3/20 0.48
IDO1 P14902 2/20 0.48
KDM1A O60341 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
MAOA P21397 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL21800796 0.98 ATM (0.52) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL27717825 0.98 ATM (0.52) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
SCHEMBL11587553 0.85 SIGMAR1 (0.59) SIGMAR1L3MBTL1MEN1KMT2A
SCHEMBL11586645 0.85 SIGMAR1 (0.59) SIGMAR1L3MBTL1MEN1KMT2A
SCHEMBL8897396 0.84 SIGMAR1 (0.50) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
SCHEMBL2911080 0.81 SIGMAR1 (0.56) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
SCHEMBL1829762 0.81 NPC1 (0.50) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
SCHEMBL30852242 0.80 TMEM97 (0.57) TAAR1SIGMAR1ALDH1A1LMNACYP3A4
SCHEMBL28475113 0.80 SIGMAR1 (0.59) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL6436425 0.79 GAA (0.50) ATMTAAR1SIGMAR1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308456-B1 COMPOSITON FOR THE TREATMENT OF THE EPIDERM SCHOEFF, Nadine (FR) 1991-12-04 EP claimed
WO-2013089689-A1 CONSTITUENT OF DESMODIUM ELEGANS AND METHODS OF USE KNELLER BRUCE W (US) 2013-06-20 WO disclosed
US-20110039324-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2011-02-17 US disclosed
EP-2220100-A2 CHIRAL CYCLOPLATINIZED COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINE AND CATALYSTS Rheinisch-Westfälisch-Technische Hochschule Aachen (DE) 2010-08-25 EP disclosed
WO-2009077462-A2 CHIRAL CYCLOPLATINIZED COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINE AND CATALYSTS Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2009-06-25 WO disclosed
US-6750255-B2 SUCH AS (R)-N-(1-(1'-NAPHTHYL)ETHYL)-2-(2',5'-DICHOROPHENYL THIO)ETHYLAMINE; FOR STIMULATION OF SECRETION OF PARATHYROID HORMONE NPS PHARMACEUTICALS, INC. 2004-06-15 US disclosed
US-20020107406-A1 Calcium receptor-active compounds NPS PHARMACEUTICALS, INC. (US) 2002-08-08 US disclosed